ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation.
about
Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung AdenocarcinomaROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survivalAnalysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment.Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis.
P2860
Q28547292-92107FE0-AAE9-43DF-AE1A-809803A8045AQ37405620-10FB6F96-6F25-49D0-95A7-3B155838B55FQ37679659-D6044217-B018-41B1-988F-A036D83C96B5Q38776722-ACC604D2-0CEB-4C95-96B9-E7A7FC5F2404Q39182547-D84EF9F9-E8A3-4A47-B48A-B02D628436A5Q42268645-0535414C-2BFB-4956-8B7D-E417D56B3B1FQ50056486-87658FED-2662-4A59-ADB0-A9D5DF77602A
P2860
ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@ast
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@en
type
label
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@ast
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@en
prefLabel
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@ast
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@en
P2093
P2860
P1476
ROR1 as a novel therapeutic ta ...... with the EGFR T790M mutation.
@en
P2093
Ana Drozdowskyj
Ana Gimenez-Capitan
Bartomeu Massuti
Cristina Teixido
Enric Carcereny
Filippo de Marinis
Miguel Angel Molina
Niki Karachaliou
Santiago Viteri
Teresa Moran
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2014.03.02
P577
2014-06-01T00:00:00Z